Comparative Pharmacology
Head-to-head clinical analysis: CENTANY versus LUMI SPORYN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CENTANY versus LUMI SPORYN.
CENTANY vs LUMI-SPORYN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mupirocin binds to isoleucyl-tRNA synthetase, inhibiting bacterial protein synthesis.
LUMI-SPORYN is a synthetic antimicrobial that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), specifically PBP3, leading to impaired cross-linking of peptidoglycan and osmotic lysis. It also exhibits concentration-dependent bactericidal activity.
Apply a thin layer to affected area twice daily for 10 days. For perioral dermatitis, apply once daily.
1000 mg IV every 8 hours over 1 hour for adults with normal renal function.
None Documented
None Documented
8-10 minutes in serum; prolonged to 15-20 minutes in patients with renal impairment. Clinical context: Rapidly cleared, infrequent dosing intervals (e.g., every 20 minutes during procedure).
6-8 hours; prolonged to 15-30 hours in severe renal impairment (CrCl <30 mL/min)
Primarily excreted unchanged in urine via glomerular filtration and tubular secretion (85-90% renal); minor biliary/fecal elimination (<5%).
Renal 70-80% unchanged, biliary/fecal 20-30%
Category C
Category C
Topical Antibiotic
Topical Antibiotic